Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Assembly Biosciences (ASMB) Current Deferred Tax Assets (2017)

Assembly Biosciences (ASMB) has 1 years of Current Deferred Tax Assets data on record, last reported at $4.9 million in Q4 2017.

  • For Q4 2017, Current Deferred Tax Assets changed N/A year-over-year to $4.9 million; the TTM value through Dec 2017 reached $4.9 million, changed N/A, while the annual FY2017 figure was $4.9 million, N/A changed from the prior year.
  • Current Deferred Tax Assets reached $4.9 million in Q4 2017 per ASMB's latest filing.
  • Across five years, Current Deferred Tax Assets topped out at $4.9 million in Q4 2017 and bottomed at $4.9 million in Q4 2017.